Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Subcellular distribution of M2 muscarinic receptors in relation to dopaminergic neurons of the rat ventral tegmental area.

The Journal of comparative neurology | 2006

Acetylcholine can affect cognitive functions and reward, in part, through activation of muscarinic receptors in the ventral tegmental area (VTA) to evoke changes in mesocorticolimbic dopaminergic transmission. Among the known muscarinic receptor subtypes present in the VTA, the M2 receptor (M2R) is most implicated in autoregulation and also may play a heteroreceptor role in regulation of the output of the dopaminergic neurons. We sought to determine the functionally relevant sites for M2R activation in relation to VTA dopaminergic neurons by examining the electron microscopic immunolabeling of M2R and the dopamine transporter (DAT) in the VTA of rat brain. The M2R was localized to endomembranes in DAT-containing somatodendritic profiles but showed a more prominent, size-dependent plasmalemmal location in nondopaminergic dendrites. M2R also was located on the plasma membrane of morphologically heterogenous axon terminals contacting unlabeled as well as M2R- or DAT-labeled dendrites. Some of these terminals formed asymmetric synapses resembling those of cholinergic terminals in the VTA. The majority, however, formed symmetric, inhibitory-type synapses or were apposed without recognized junctions. Our results provide the first ultrastructural evidence that the M2R is expressed, but largely not available for local activation, on the plasma membrane of VTA dopaminergic neurons. Instead, the M2R in this region has a distribution suggesting more indirect regulation of mesocorticolimbic transmission through autoregulation of acetylcholine release and changes in the physiological activity or release of other, largely inhibitory transmitters. These findings could have implications for understanding the muscarinic control of cognitive and goal-directed behaviors within the VTA.

Pubmed ID: 16927256 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Associated grants

  • Agency: NIDA NIH HHS, United States
    Id: DA005130
  • Agency: NIDA NIH HHS, United States
    Id: P60 DA005130
  • Agency: NIMH NIH HHS, United States
    Id: MH40342
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA004600
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH040342
  • Agency: NIDA NIH HHS, United States
    Id: P50 DA005130
  • Agency: NIDA NIH HHS, United States
    Id: DA04600
  • Agency: NIMH NIH HHS, United States
    Id: R37 MH040342
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH040342-24

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Adobe Illustrator (tool)

RRID:SCR_010279

Vector graphics software to create digital graphics, illustrations, and typography for several types of media: print, web, interactive, video, and mobile.

View all literature mentions

Anti-CHRM2 Antibody (antibody)

RRID:AB_2039995

This unknown targets Muscarinic Acetylcholine Receptor M2

View all literature mentions

MAB369 | Anti-Dopamine Transporter Antibody, NT, clone DAT-Nt (antibody)

RRID:AB_2190413

This monoclonal targets Dopamine Transporter N-terminus clone DAT-Nt

View all literature mentions